Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ω-3 PN in Crohn's Disease
NCT03901937Phase 4Unknown
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Mar 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of omega-3-acid triglycerides in Crohn's disease (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoint: Rate of Postoperative complications. Status: unknown.
02
Drugs
omega-3-acid triglycerides
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT03901937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03901937.